Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Bladder Dysfunction Reports
Erschienen in: Current Bladder Dysfunction Reports 1/2015

01.03.2015 | Overactive Bladder (U Lee, Section Editor)

Challenges in the Treatment of Overactive Bladder in the Octogenarian Female

verfasst von: Lisa Rogo-Gupta

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this paper is to discuss overactive bladder (OAB) treatment in the octogenarian female with focus on diagnosis, treatment options, and recent advances relevant to practicing physicians. OAB treatment in the octogenarian female should be individualized. Each patient has her own physical and mental limitations, support system, and treatment expectations. Physicians should assess patients in the overall context of their medical conditions and lifestyle, identify and treat reversible causes, reassess symptoms and continence goals, devise a feasible treatment plan, and follow for symptom improvement. Behavior and lifestyle modifications remain first line for OAB treatment in octogenarians. Age is not a contraindication to medical therapy. OAB procedures are generally low risk and require minimal or no anesthesia. Recent advances include two medications (Myrbetriq™, Oxytrol® for women) and three procedures (sacral neuromodulation, tibial nerve stimulation, onabotulinum toxin).
Literatur
1.
Haylen BT et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.PubMed
2.
Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med. 2001;135(8 Pt 2):642–6.CrossRefPubMed
3.
4.
5.••
Wagg, A., et al., Urinary incontinence in frail elderly persons: report from the 5th International Consultation on Incontinence. Neurourol Urodyn, 2014. Review of evidenced-based management of UI in the frail elderly with management recommendations.
6.
Nygaard IE, Lemke JH. Urinary incontinence in rural older women: prevalence, incidence and remission. J Am Geriatr Soc. 1996;44(9):1049–54.PubMed
7.
Talley KM et al. Factors associated with toileting disability in older adults without dementia living in residential care facilities. Nurs Res. 2014;63(2):94–104.CrossRefPubMed
8.
Anger JT et al. True prevalence of urinary incontinence among female nursing home residents. Urology. 2006;67(2):281–7.CrossRefPubMed
9.
Gronstedt H et al. Effects of individually tailored physical and daily activities in nursing home residents on activities of daily living, physical performance and physical activity level: a randomized controlled trial. Gerontology. 2013;59(3):220–9.CrossRefPubMed
10.
Vinsnes AG et al. Effect of physical training on urinary incontinence: a randomized parallel group trial in nursing homes. Clin Interv Aging. 2012;7:45–50.CrossRefPubMedCentralPubMed
11.
Gillespie LD et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;9, CD007146.PubMed
12.
Hu TW et al. Estimated economic costs of overactive bladder in the United States. Urology. 2003;61(6):1123–8.CrossRefPubMed
13.
Caffrey CSM, Park-Lee E. Residents living in residential care facilities: United States, 2010. NCHS data brief, no 91. Hyattsville: National Center for Health Statistics; 2012.
14.
Strehblow C, Smeikal M, Fasching P. Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients. Wien Klin Wochenschr. 2014;126(7–8):195–200.CrossRefPubMed
15.
Onder G et al. Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing. 2013;42(3):284–91.CrossRefPubMed
16.
Wagg A et al. Flexible-dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trial. J Am Geriatr Soc. 2013;61(2):185–93.CrossRefPubMed
17.
Sand PK et al. Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: post hoc analysis of pooled data from two randomized, placebo-controlled trials. Drugs Aging. 2011;28(2):151–60.CrossRefPubMed
18.
Sand PK et al. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged >/= 75 years) with overactive bladder syndrome. BJU Int. 2011;107(4):612–20.CrossRefPubMed
19.•
Madhuvrata P et al. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev. 2012;1:CD005429. Review of evidence-based pharmacologic management of UI in adults. PubMed
20.
Jayarajan J, Radomski SB. Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life. Res Rep Urol. 2013;6:1–16.PubMedCentralPubMed
21.
Simard C, Tule M. Long-term efficacy of pelvic floor muscle rehabilitation for older women with urinary incontinence. J Obstet Gynaecol Can. 2010;32(12):1163–6.PubMed
22.••
Gormley EA et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188(6 Suppl):2455–63. Review of evidenced-based management of OAB in adults including recent treatment advances. CrossRefPubMed
23.
Griebling TL. Sacral nerve stimulation in the elderly. Int Urogynecol J. 2010;21 Suppl 2:S485–9.CrossRefPubMed
24.
Angioli R et al. Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up. Int Urogynecol J. 2013;24(5):789–94.CrossRefPubMed
Metadaten
Titel
Challenges in the Treatment of Overactive Bladder in the Octogenarian Female
verfasst von
Lisa Rogo-Gupta
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 1/2015
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-014-0281-4

Weitere Artikel der Ausgabe 1/2015

Current Bladder Dysfunction Reports 1/2015 Zur Ausgabe

Overactive Bladder (U Lee, Section Editor)

Diet Modification for Overactive Bladder: an Evidence-Based Review

Stress Incontinence and Prolapse (R Dmochowski, Section Editor)

Avoiding and Managing Complications of Synthetic Midurethral Slings

Stress Incontinence and Prolapse (R Dmochowski, Section Editor)

The Current Role of Retropubic Suspensions

Overactive Bladder (U Lee, Section Editor)

Does Cystocele Repair Improve Overactive Bladder Symptoms?

Overactive Bladder (U Lee, Section Editor)

Evaluation and Treatment of Overactive Bladder after History of Cancer Treatment

Stress Incontinence and Prolapse (R Dmochowski, Section Editor)

Diagnosis and Management of Stress Urinary Incontinence in Females With Neurogenic Disease

Neu im Fachgebiet Urologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise